BMI SYSTEM is proud to organize a breakfast seminar for the 1st year of introduction of the Bribery Act and its implication for the Pharmaceutical industry. In this seminar will be discussed a summary of the Bribery Act and what should be expected for the future, the procedures to set-up in order to prevent bribery in an orgaisation and the tools available in order to help life science companies to implement these procedures.
Compliance, a major trend: UK pharmaceutical regulation is becoming tighter and tighter for laboratories, especially with the introduction of the Bribery Act and the recent revision of the ABPI code. This is a worldwide trend for more transparency with stakeholders in the industry and a need to improve reporting and traceability of pharmaceutical requirements.
Transparency in relationships between the life science industry and health professionals continues to gain momentum. A pan-European roadmap for the disclosure of payments made in 2016 to health professionals has been approved by the EFPIA and this measure will already be starting from 2013 in the UK according to the clause 19.4 of the ABPI Code 2012.
The Bribery Act applied to Pharmaceutical companies
Breakfast seminar 20th September 2012 in London SW1Y
Date: 20 September 2012
Time: 09.00 – 11.00
Venue: Ubifrance – The French Trade Commission, Haymarket House, 28 Haymarket, London, SW1Y 4SP
Programme:
09.00 – Registration over tea and coffee 09.25 – Introduction Laurent Clerc, Managing Director, BMI SYSTEM Ltd 09.30 – An overview of the Bribery Act David Glass, Senior Partner, Pritchard Engelfield 09.50 – How to implement the Bribery Act in your organisation Steve Gray, Managing Director, Compliance Hub 10.10 – Tools to manage critical processes Laurent Clerc, Managing Director, BMI SYSTEM Ltd 10.30 – Closing remarks and Q&A 10.40 – Networking over tea and coffee 11.00 – Close
This seminar is free of charge.
